Danaher Corporation has announced a collaboration with AstraZeneca for diagnostic tools and tests development and ...

AstraZeneca Pharma India posts 48% rise in Q4FY25 net profit to Rs 58.25 crore, driven by strong growth in oncology and ...

AstraZeneca Pharma India Limited reported a strong financial performance for the fourth quarter ended March 31, 2025. The ...

This is a historic moment in decades-long efforts to appropriately address the needs of the hundreds of millions worldwide ...

Antibody-drug conjugates have become a “choose your own adventure” tool in pharma R&D. Due to their versatility, the ...

Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the ...

Danaher Corp on Thursday said it has entered a partnership with AstraZeneca PLC to develop and commercialise tools and tests for precision medicine treatments, including artificial intelligence ...

Danaher and AstraZeneca have formed a partnership to develop diagnostic tools that help clinicians better determine which patients would benefit from precision medicine treatments.

The Committee for Medicinal Products for Human Use (CHMP) has recommended that Imfinzi be used in combination with ...

The foreign trade value of foreign-invested businesses reached 4.1 trillion yuan (£423.81 billion) in China between January ...

UK stock markets have ended the month in the green as markets remain steady in the face of persistent uncertainty over Donald ...

Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product ...